Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B McInnes

Showing results (351-360 of 537) with videos related to

Pageof 54
Sort By:
Nature Communications|April 11, 2015
MicroRNA29a regulates IL-33-mediated tissue remodelling in tendon diseaseNeal L Millar, Derek S Gilchrist, Moeed Akbar, et al.
Rheumatology (Oxford, England)|April 12, 2021
Comparative effectiveness of guselkumab in psoriatic arthritis: results from systematic literature review and network meta-analysisPhilip J Mease, Iain B McInnes, Lai-Shan Tam, et al.
Annals of the Rheumatic Diseases|March 14, 2013
Open-label tofacitinib and double-blind atorvastatin in rheumatoid arthritis patients: a randomised studyIain B McInnes, Ho-Youn Kim, Sang-Heon Lee, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|September 24, 2017
A Randomized Phase IIb Study of Mavrilimumab and Golimumab in Rheumatoid ArthritisMichael E Weinblatt, Iain B McInnes, Joel M Kremer, et al.
British Journal of Pharmacology|January 26, 2013
IL-33/ST2 signalling contributes to carrageenin-induced innate inflammation and inflammatory pain: role of cytokines, endothelin-1 and prostaglandin E2A C Zarpelon, T M Cunha, J C Alves-Filho, et al.
Medicine|June 27, 2020
Targeting the rheumatoid arthritis synovial fibroblast via cyclin dependent kinase inhibition: An early phase trialStefan Siebert, Arthur G Pratt, Deborah D Stocken, et al.
Cytokine|July 4, 2012
Interleukin-21--a biomarker of importance in predicting myocardial function following acute infarction?Robin A P Weir, Ashley M Miller, Colin J Petrie, et al.
European Journal of Immunology|June 16, 2011
IL-33 induces skin inflammation with mast cell and neutrophil activationAxel J Hueber, Jose C Alves-Filho, Darren L Asquith, et al.
ACR Open Rheumatology|October 4, 2024
Persistent Patient-Level Effect of Guselkumab at Consecutive 8-Week Dosing Visits and Over Time in Patients With Active Psoriatic Arthritis: Post Hoc Analysis of a 2-Year, Phase 3, Randomized, Controlled StudyPhilip J Mease, Xenofon Baraliakos, Vinod Chandran, et al.
Rheumatology (Oxford, England)|June 7, 2021
Effect of the phosphodiesterase 4 inhibitor apremilast on cardiometabolic outcomes in psoriatic disease-results of the Immune Metabolic Associations in Psoriatic Arthritis studyLyn D Ferguson, Susanne Cathcart, Dominic Rimmer, et al.
Pageof 54

Showing results (351-360 of 537) with videos related to

Sort By:
Pageof 54
Nature Communications|April 11, 2015
MicroRNA29a regulates IL-33-mediated tissue remodelling in tendon diseaseNeal L Millar, Derek S Gilchrist, Moeed Akbar, et al.
Rheumatology (Oxford, England)|April 12, 2021
Comparative effectiveness of guselkumab in psoriatic arthritis: results from systematic literature review and network meta-analysisPhilip J Mease, Iain B McInnes, Lai-Shan Tam, et al.
Annals of the Rheumatic Diseases|March 14, 2013
Open-label tofacitinib and double-blind atorvastatin in rheumatoid arthritis patients: a randomised studyIain B McInnes, Ho-Youn Kim, Sang-Heon Lee, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|September 24, 2017
A Randomized Phase IIb Study of Mavrilimumab and Golimumab in Rheumatoid ArthritisMichael E Weinblatt, Iain B McInnes, Joel M Kremer, et al.
British Journal of Pharmacology|January 26, 2013
IL-33/ST2 signalling contributes to carrageenin-induced innate inflammation and inflammatory pain: role of cytokines, endothelin-1 and prostaglandin E2A C Zarpelon, T M Cunha, J C Alves-Filho, et al.
Medicine|June 27, 2020
Targeting the rheumatoid arthritis synovial fibroblast via cyclin dependent kinase inhibition: An early phase trialStefan Siebert, Arthur G Pratt, Deborah D Stocken, et al.
Cytokine|July 4, 2012
Interleukin-21--a biomarker of importance in predicting myocardial function following acute infarction?Robin A P Weir, Ashley M Miller, Colin J Petrie, et al.
European Journal of Immunology|June 16, 2011
IL-33 induces skin inflammation with mast cell and neutrophil activationAxel J Hueber, Jose C Alves-Filho, Darren L Asquith, et al.
ACR Open Rheumatology|October 4, 2024
Persistent Patient-Level Effect of Guselkumab at Consecutive 8-Week Dosing Visits and Over Time in Patients With Active Psoriatic Arthritis: Post Hoc Analysis of a 2-Year, Phase 3, Randomized, Controlled StudyPhilip J Mease, Xenofon Baraliakos, Vinod Chandran, et al.
Rheumatology (Oxford, England)|June 7, 2021
Effect of the phosphodiesterase 4 inhibitor apremilast on cardiometabolic outcomes in psoriatic disease-results of the Immune Metabolic Associations in Psoriatic Arthritis studyLyn D Ferguson, Susanne Cathcart, Dominic Rimmer, et al.
Pageof 54